All In MedTech

Device Trial Radar · NCT02368080

Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults

Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis Adults: a Comparison of Two Commercially Available Devices

Last checked: Nov 19, 2026Latest source record: Jul 30, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

95

Actual

Start

Apr 2013

Primary completion

Dec 2013

Study completion Jan 2014

Sponsor

Sponsor type
Academic, hospital or other
First posted
Feb 20, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study compares the lung clearance index (LCI) in cystic fibrosis and healthy adults obtained with two different multiple breath nitrogen washout (MBWN2) devices. Each participants will perform the test (LCI) in duplicate on each device.

Conditions

  • Cystic Fibrosis
  • Healthy

Interventions

  • Comparison of two MBWN2 devices : "EasyOne Pro Lab" versus "Exhalyzer D"Device

    Healthy and Cystic Fibrosis participants will perform the same day MBWN2 tests in duplicate with each device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lung Clearance Index (LCI)Time frame: 1 hour

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cliniques universitaires Saint-Luc

    Brussels, Belgium

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.